RxDoctor Payments Data

Renee Grau, MD

Dermatology · Oklahoma City, OKNPI 1861445991

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 367 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations.

$6,698in general payments, 2019–2025

Across 367 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$1K
  • Pfizer$942
  • E.r. Squibb & Sons, L.L.C.$874
  • Johnson & Johnson$698
  • Arcutis Biotherapeutics, Inc.$511
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$6,58098%
  • Education$1182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,698 in reported general payments places this provider in the 65th percentile of 114 dermatology providers in Oklahoma.

See all dermatology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$319,844
Medicare patients
1,083
Services billed
5,558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa14$299,958
Cosentyx Unoready PenSecukinumab13$123,561
Acitretin12$6,255
Doxycycline Hyclate56$4,350
Fluconazole147$2,779
Clobetasol Propionate50$2,549
Finasteride165$1,927
ValacyclovirValacyclovir Hcl58$1,852
Mometasone Furoate71$1,795
Imiquimod51$1,684
Minoxidil160$1,561
Metronidazole23$1,540
Ketoconazole79$1,521
Tretinoin15$1,188
Spironolactone63$1,012

Paid to pharmacies, not to this prescriber.

Other dermatology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →